Cell line · CVCL_B478
Papers73
1 to 20 of 73
Download this page as JSON| Paper | Journal | Year | How we know | Retracted | Source |
|---|---|---|---|---|---|
| Immunogenicity and structure of a stabilized HIV-1 clade C Env from a pediatric elite neutralizer in complex with an autologous bnAb. | Front Immunol | 2026 | Its Methods give the RRID and name the line | PubMed | |
| HIV-1 Infection Alters Post-Transcriptional Processing of HTLV-1 RNA in MT-2 Cells. | Microorganisms | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Distinct allosteric remodeling of HIV-1 Env dynamics on virions by gp41-directed antibodies reveals two modes of neutralization. | Elife | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Canonical Antibodies Adopt Distinct Binding Modes to Recognize Viral Glycan Shields. | Adv Sci (Weinh) | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Siglec-1-targeted nanobodies restrict HIV-1 transmission and infection of dendritic cells. | J Virol | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Adjuvants MPLA and SMNP induce antiviral immunity and indirectly revert HIV-1 latency. | PLoS One | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Capsid and integrase play essential apposing roles in viral ribonucleoprotein assembly during HIV-1 core morphogenesis. | iScience | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Antibody-mediated targeting of SOSIP HIV-1 Env to skin Langerhans cells potentiates humoral responses. | EBioMedicine | 2026 | Its Methods give the RRID and name the line | PubMed | |
| HIV broadly neutralizing antibody escape dynamics drive the outcome of AAV-vectored immunotherapy in humanized mice. | Immunity | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Virus glycoprotein nanodisc platform for vaccine analytics. | Nat Commun | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Transmission of Non-Constitutive Proteasomes Between Cells via Extracellular Vesicles. | Int J Mol Sci | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Identification and Characterization of an In Silico Designed Membrane-Active Peptide with Antiviral Properties. | Adv Sci (Weinh) | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Immune and viral surveillance of HIV-1C reservoirs in an Indian cohort. | iScience | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Lenacapavir-induced capsid damage uncovers HIV-1 genomes emanating from nuclear speckles. | EMBO J | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Lithium attenuates HIV-1 latency reversal in an autophagy-independent way. | iScience | 2025 | Its Methods give the RRID and name the line | PubMed | |
| Evasion of CARD8 activation during HIV-1 assembly. | Sci Adv | 2025 | Its Methods give the RRID and name the line | PubMed | |
| Simultaneous priming of HIV broadly neutralizing antibody precursors to multiple epitopes by germline-targeting mRNA-LNP immunogens in mouse models. | Sci Immunol | 2025 | Its Methods give the RRID and name the line | PubMed | |
| Experimental medicine study with stabilised native-like HIV-1 Env immunogens drives long-term antibody responses, but lacks neutralising breadth. | EBioMedicine | 2025 | Its Methods give the RRID and name the line | PubMed | |
| HIV broadly neutralizing antibody escape dynamics drive the outcome of AAV vectored immunotherapy in humanized mice. | bioRxiv | 2025 | Its Methods give the RRID and name the line | PubMed | |
| Bivalent SMAC mimetic APG-1387 reduces HIV reservoirs and limits viral rebound in humanized mice. | iScience | 2024 | Its Methods give the RRID and name the line | PubMed |
cell-lines-2026-11-14-0.1.0
Sources 4
- CellosaurusCC BY 4.0, with credit to Cellosaurus (SIB)
- PubMed Central's articlesTitles shown only for CC0, CC BY and public domain articles
- NLM's PMC Article DatasetsCourtesy of NLM, which does not endorse this database
- PubMedNLM's terms
Each source's terms
- CellosaurusCC BY 4.0. Cellosaurus's README: "we have chosen to apply the Creative Commons Attribution 4.0 International (CC BY 4.0) license to Cellosaurus (https://creativecommons.org/licenses/by/4.0/). This means that you are free to copy and redistribute Cellosaurus in any medium or format. You can remix, transform, and build upon Cellosaurus for any purpose, even commercially. You must give appropriate credit, provide a link to the license, and indicate if changes were made." Copyright (c) CALIPHO group, SIB Swiss Institute of Bioinformatics. Read on 14 Nov 2026 at https://ftp.expasy.org/databases/cellosaurus/README
- PubMed Central's articlesEach article's own license. Its words show only under CC0, CC BY or public domain
- NLM's PMC Article DatasetsNLM's PMC Article Datasets on AWS, https://registry.opendata.aws/ncbi-pmc. Its terms: users "acknowledge NLM as the source of the data in a clear and conspicuous manner", do not use the PubMed Central wordmark or the PMC logo, do not "indicate or imply that NLM/NIH/HHS has endorsed" a product, and "only distribute data that are licensed for redistribution". Each article keeps its own license: https://pmc.ncbi.nlm.nih.gov/about/copyright/
- PubMedNLM's terms
Cellosaurus, SIB Swiss Institute of Bioinformatics, https://www.cellosaurus.org, CC BY 4.0. Its problem notes are given in its own words.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/cell-lines/v1/CVCL_B478/papers